January 14, 2026 8:57 pm

Tag: Crohn’s symptoms

New Hope for Severe Crohn’s: Breakthrough Drug Targets Scarring

Agomab Therapeutics has launched a groundbreaking clinical trial for ontunisertib, a drug specifically targeting fibrostenosing Crohn’s disease—the severe, scarring form that has limited treatment options. This represents the first targeted therapy designed to address the root cause of intestinal scarring rather than just managing symptoms.

You Missed

Breakthrough in Crohn's Treatment: New Experimental Drug Offers Hope for Remission

Breakthrough in Crohn’s Treatment: New Experimental Drug Offers Hope for Remission

January 11, 2026
Young Adults with IBD Navigate Complex Healthcare Barriers and Financial Strain

Young Adults with IBD Navigate Complex Healthcare Barriers and Financial Strain

January 11, 2026
The Six-Week Journey Back: My IBD Flare Recovery Roadmap

The Six-Week Journey Back: My IBD Flare Recovery Roadmap

January 11, 2026
When My Skin Became the Battlefield: Living with Pyoderma Gangrenosum and Crohn's Disease

When My Skin Became the Battlefield: Living with Pyoderma Gangrenosum and Crohn’s Disease

January 10, 2026